PSA test valuable in predicting biopsy need, low-risk prostate cancer, study finds

The prostate-precise antigen examination, generally acknowledged as the PSA check, is useful in predicting which men ought to have biopsies and which are likely to be diagnosed with low-danger prostate cancer, a new study has found.
Reference: ScienceDaily: Men’s Health Information

Posts Related to PSA test valuable in predicting biopsy need, low-risk prostate cancer, study finds

Cancer biomarker — detectable by blood test — could improve prostate cancer detection
A new study supports the use of a DNA-based "biomarker" blood test as a complement to the prostate-specific antigen test currently offered to screen men ...
Rise found in prostate biopsy complications and high post-procedure hospitalization rate
In a study of complication rates following prostate biopsy among Medicare beneficiaries, researchers have found a significant rise in serious complications requiring hospitalization. The researchers ...
Two new cost-effective ways to predict prostate cancer
Two related studies reveal new risk indicators for prostate cancer. The first study shows that men diagnosed with benign prostate enlargement have an increased risk ...
New urine test shows prostate cancer risk; Test for gene fusion can assist in the early detection of prostate cancer
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a new study finds. Reference: ScienceDaily: Men's Health News
New prostate cancer screening test shows promise for diagnosis
A new prostate screening test may prove to be a promising new tool in the diagnosis of prostate cancer. The study found that this new ...